#70 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
“This journal publishes across a wide spectrum of evidence quality, from basic science to clinical trials, so any practitioner reading it needs to carefully distinguish between preliminary laboratory findings and rigorous human studies before integrating claims into clinical practice. The impact factor reflects solid peer review, but that doesn’t mean every paper carries equal weight for patient care decisions.”
🔬 Cannabis & Cannabinoid Research serves as an important peer-reviewed forum for emerging evidence on cannabis pharmacology and clinical applications, though clinicians should recognize that the field remains fragmented with variable study quality and limited long-term safety data. The journal’s moderate impact factor and interdisciplinary scope reflect both genuine scientific progress and the heterogeneity of cannabinoid research, which spans basic chemistry, preclinical models, and small clinical trials with differing methodologies and patient populations. Key confounders include the wide variation in cannabinoid ratios, delivery methods, dosing regimens, and individual genetic factors affecting cannabinoid metabolism that make generalizing findings across studies challenging. Practitioners considering cannabinoid-based interventions should use this journal selectively as one evidence source while maintaining awareness that most published research remains preliminary, regulatory approval remains limited for most conditions, and robust head-to-head comparisons with established treatments are still scarce
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
